STOCK TITAN

[S-8] ICU Medical Inc Employee Benefit Plan Registration

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
S-8

ICU Medical registered 2,150,000 shares of its common stock for issuance under the Third Amendment to its Amended and Restated 2011 Stock Incentive Plan, approved by stockholders at the 2025 annual meeting on May 13, 2025. The filing confirms these additional shares are the same class as prior awards and incorporates earlier Form S-8 and 10-K registrations by reference, and includes related exhibits and legal opinions.

ICU Medical ha registrato 2.150.000 azioni ordinarie da emettere ai sensi della Terza Emendamento al suo Piano di Incentivazione Azionaria del 2011 modificato e riformulato, approvato dagli azionisti nell'assemblea annuale del 13 maggio 2025. Il deposito conferma che queste azioni aggiuntive appartengono alla stessa categoria delle precedenti assegnazioni, incorpora per riferimento le precedenti registrazioni sui moduli S-8 e 10-K e include gli allegati e i pareri legali correlati.

ICU Medical registró 2.150.000 acciones ordinarias para su emisión en virtud de la Tercera Enmienda a su Plan de Incentivos en Acciones de 2011, enmendado y reformulado, aprobado por los accionistas en la junta anual del 13 de mayo de 2025. La presentación confirma que estas acciones adicionales son de la misma clase que las adjudicaciones anteriores, incorpora por referencia las inscripciones previas en los formularios S-8 y 10-K e incluye los anexos y dictámenes legales relacionados.

ICU Medical는 2025년 5월 13일 열린 연례 주주총회에서 승인된 수정·재작성된 2011년 주식 인센티브 플랜의 제3차 개정안에 따라 발행하기 위해 2,150,000주의 보통주를 등록했습니다. 이번 제출 서류는 이 추가 주식들이 이전 수여분과 동일한 종류임을 확인하고, 이전의 Form S-8 및 10-K 등록을 참조로 포함하며 관련 전시자료와 법률 의견서를 포함합니다.

ICU Medical a enregistré 2 150 000 actions ordinaires en vue de leur émission au titre du troisième amendement de son plan d'incitation en actions de 2011 modifié et refondu, approuvé par les actionnaires lors de l'assemblée générale annuelle du 13 mai 2025. Le dépôt confirme que ces actions supplémentaires sont de la même catégorie que les attributions antérieures, intègre par renvoi les enregistrements antérieurs sur les formulaires S-8 et 10-K et comprend les annexes et avis juridiques correspondants.

ICU Medical hat 2.150.000 Aktien seiner Stammaktien zur Ausgabe im Rahmen des dritten Nachtrags zu seinem geänderten und neu gefassten Aktienanreizplan von 2011 registriert, der von den Aktionären auf der Hauptversammlung am 13. Mai 2025 genehmigt wurde. Die Einreichung bestätigt, dass diese zusätzlichen Aktien derselben Klasse wie frühere Zuteilungen angehören, nimmt frühere Registrierungen in den Formularen S-8 und 10-K durch Verweisung auf und enthält zugehörige Anlagen und Rechtsgutachten.

Positive
  • 2,150,000 additional shares have been registered for issuance under the company's 2011 Stock Incentive Plan
  • Stockholder approval of the Third Amendment was obtained at the 2025 annual meeting
  • Registration incorporates prior S-8 and 10-K filings, enabling issuance without a new standalone registration
  • Filing includes legal opinion and auditor consent exhibits to support the registration
Negative
  • Authorization to issue additional shares could increase the company’s outstanding share count if awards are granted
  • Form S-8 provides no financial results or impact analysis; it only registers shares for plan awards

Insights

TL;DR: Routine equity refresh: 2.15M shares added to the employee plan to support awards and retention.

The Third Amendment increases the pool available under the Amended and Restated 2011 Stock Incentive Plan by 2,150,000 shares. This is a common corporate action to fund future restricted stock and performance awards for employees and executives. The registration via Form S-8 and incorporation by reference to prior filings ensures these shares are cleared for issuance without a separate registration, streamlining grant processes.

TL;DR: Stockholder-approved amendment shows governance process followed; filing documents and consents are included.

The amendment was approved by stockholders at the company's 2025 annual meeting, indicating shareholder consent for the increased award capacity. The registration statement attaches legal opinion and auditor consent exhibits, and incorporates prior S-8 and 10-K filings by reference, reflecting standard disclosure practice for employee benefit plan registrations.

ICU Medical ha registrato 2.150.000 azioni ordinarie da emettere ai sensi della Terza Emendamento al suo Piano di Incentivazione Azionaria del 2011 modificato e riformulato, approvato dagli azionisti nell'assemblea annuale del 13 maggio 2025. Il deposito conferma che queste azioni aggiuntive appartengono alla stessa categoria delle precedenti assegnazioni, incorpora per riferimento le precedenti registrazioni sui moduli S-8 e 10-K e include gli allegati e i pareri legali correlati.

ICU Medical registró 2.150.000 acciones ordinarias para su emisión en virtud de la Tercera Enmienda a su Plan de Incentivos en Acciones de 2011, enmendado y reformulado, aprobado por los accionistas en la junta anual del 13 de mayo de 2025. La presentación confirma que estas acciones adicionales son de la misma clase que las adjudicaciones anteriores, incorpora por referencia las inscripciones previas en los formularios S-8 y 10-K e incluye los anexos y dictámenes legales relacionados.

ICU Medical는 2025년 5월 13일 열린 연례 주주총회에서 승인된 수정·재작성된 2011년 주식 인센티브 플랜의 제3차 개정안에 따라 발행하기 위해 2,150,000주의 보통주를 등록했습니다. 이번 제출 서류는 이 추가 주식들이 이전 수여분과 동일한 종류임을 확인하고, 이전의 Form S-8 및 10-K 등록을 참조로 포함하며 관련 전시자료와 법률 의견서를 포함합니다.

ICU Medical a enregistré 2 150 000 actions ordinaires en vue de leur émission au titre du troisième amendement de son plan d'incitation en actions de 2011 modifié et refondu, approuvé par les actionnaires lors de l'assemblée générale annuelle du 13 mai 2025. Le dépôt confirme que ces actions supplémentaires sont de la même catégorie que les attributions antérieures, intègre par renvoi les enregistrements antérieurs sur les formulaires S-8 et 10-K et comprend les annexes et avis juridiques correspondants.

ICU Medical hat 2.150.000 Aktien seiner Stammaktien zur Ausgabe im Rahmen des dritten Nachtrags zu seinem geänderten und neu gefassten Aktienanreizplan von 2011 registriert, der von den Aktionären auf der Hauptversammlung am 13. Mai 2025 genehmigt wurde. Die Einreichung bestätigt, dass diese zusätzlichen Aktien derselben Klasse wie frühere Zuteilungen angehören, nimmt frühere Registrierungen in den Formularen S-8 und 10-K durch Verweisung auf und enthält zugehörige Anlagen und Rechtsgutachten.

As filed with the Securities and Exchange Commission on August 8, 2025

Registration No. 333-   

 

 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

 

ICU MEDICAL, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   33-0022692
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)
951 Calle Amanecer
San Clemente, California
  92673
(Address of Principal Executive Offices)   (Zip Code)

Amended and Restated ICU Medical, Inc. 2011 Stock Incentive Plan

(Full title of the Plan)

Brian M. Bonnell

Chief Financial Officer

ICU Medical, Inc.

951 Calle Amanecer

San Clemente, California 92673

(Name and address of agent for service)

(949) 366-2183

(Telephone number, including area code, of agent for service)

Copy to:

Daniel E. Rees

Latham & Watkins LLP

650 Town Center Drive, 20th Floor

Costa Mesa, California 92626

(714) 540-1235

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer      Accelerated filer  
Non-accelerated filer      Smaller reporting company  
     Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 

 
 


EXPLANATORY NOTE

This Registration Statement on Form S-8 (the “Registration Statement”) is filed by ICU Medical, Inc. (the “Company”) relating to the registration of 2,150,000 shares of the Company’s common stock, par value $0.10 per share (the “Common Stock”), that may become issuable under the Third Amendment (the “Third Amendment”) to the Company’s Amended and Restated 2011 Stock Incentive Plan (the “2011 Plan” and as amended by the Third Amendment, the “Plan”). The Third Amendment was approved by the Company’s stockholders at the Company’s 2025 annual meeting of stockholders on May 13, 2025. The additional shares registered pursuant to the Plan are of the same class as other securities relating to the 2011 Plan, for which registration statements of the Company on Form S-8  (File Nos. 333-270546, 333-219106 and 333-198256) are effective.

Pursuant to General Instruction E of Form S-8, the contents of the above-referenced registration statements are incorporated into this Registration Statement by reference to the extent not modified or superseded hereby or by any subsequently filed document, which is incorporated by reference herein or therein.

Item 8. Exhibits.

 

Exhibit
Number
  

Exhibit Description

   Incorporated by Reference      Filed
Herewith
 
   Form      Date      Number  
  4.1    Certificate of Incorporation of ICU Medical, Inc., as amended and restated      8-K        06/10/2014        3.1     
  4.2    Bylaws of ICU Medical, Inc., as amended and restated      8-K        11/03/2023        3.1     
  5.1    Opinion of Latham & Watkins LLP               X  
 23.1    Consent of Latham & Watkins LLP (included in Exhibit 5.1)               X  
 23.2    Consent of Deloitte & Touche LLP, independent registered public accounting firm for the Company               X  
 24.1    Power of Attorney (included on signature page)               X  
 99.1    Amended and Restated ICU Medical, Inc. 2011 Stock Incentive Plan      10-K        02/27/2023        10.6     
 99.2    First Amendment to ICU Medical, Inc. Amended and Restated 2011 Stock Incentive Plan      10-K        03/02/2020        10.12     
 99.3    Second Amendment to ICU Medical, Inc. Amended and Restated 2011 Stock Incentive Plan      8-K        05/22/2023        10.1     
 99.4    Third Amendment to ICU Medical, Inc. Amended and Restated 2011 Stock Incentive Plan      8-K        05/14/2025        10.1     
 99.5    Form of Amended and Restated 2011 Stock Incentive Plan Restricted Stock Unit Award Agreement      S-8        03/15/2023        99.4     
 99.6    Form of Amended and Restated 2011 Stock Incentive Plan Performance Restricted Stock Unit Award Agreement      S-8        03/15/2023        99.5     
107    Filing Fee Table               X  


SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Clemente, State of California, on this 8th day of August 2025.

 

ICU MEDICAL, INC.
By:   /s/ Brian M. Bonnell
  Brian M. Bonnell
Chief Financial Officer


POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below does hereby constitute and appoint Vivek Jain, Brian M. Bonnell and Virginia Sanzone, and each of them, with full power of substitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act for him or her in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to file this registration statement, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in order to effectuate the same as fully, to all intents and purposes, as they or he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the date indicated.

 

Signature

  

Title

 

Date

/s/ Vivek Jain

Vivek Jain

   Chairman of the Board and Chief Executive Officer
(Principal Executive Officer)
  August 8, 2025

/s/ Brian M. Bonnell

Brian M. Bonnell

   Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)
  August 8, 2025

/s/ Elisha W. Finney

Elisha W. Finney

   Director   August 8, 2025

/s/ Donald M. Abbey

Donald M. Abbey

   Director   August 8, 2025

/s/ David F. Hoffmeister

David F. Hoffmeister

   Director   August 8, 2025

/s/ David C. Greenberg

David C. Greenberg

   Director   August 8, 2025

/s/ Laurie Hernandez

Laurie Hernandez

   Director   August 8, 2025

/s/ Kolleen T. Kennedy

Kolleen T. Kennedy

   Director   August 8, 2025

FAQ

How many shares did ICU Medical (ICUI) register on Form S-8?

The company registered 2,150,000 shares of its common stock for issuance under the amended 2011 Stock Incentive Plan.

Which plan covers the newly registered shares for ICUI?

The shares are registered under the Amended and Restated 2011 Stock Incentive Plan as modified by the Third Amendment.

Was the Third Amendment approved by shareholders for ICUI?

Yes; the Third Amendment was approved by the company’s stockholders at the 2025 annual meeting on May 13, 2025.

Are the additional shares the same class as previously registered awards?

Yes; the filing states the additional shares are of the same class as other securities previously registered for the 2011 Plan.

Where can I find the Third Amendment document referenced in the filing?

The Third Amendment is included as Exhibit 99.4 and was filed on an 8-K dated 05/14/2025 as Exhibit 10.1.
Icu Medical

NASDAQ:ICUI

ICUI Rankings

ICUI Latest News

ICUI Latest SEC Filings

ICUI Stock Data

2.90B
23.97M
3.14%
113.48%
5.47%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
SAN CLEMENTE